Dr. Calsyn is a Professor in the Department of Psychiatry and Behavioral Sciences. Before coming to ADAI, he was also the Director of Outpatient Services at the Addictions Treatment Center of the VA Puget Sound Health Care System. Dr. Calsyn has been involved with clinical research focusing on methadone clients, their characteristics, and different approaches to their treatment, including contingency management. Much of his work has focused on HIV/AIDS risk behaviors among IV drug abusers and preventive interventions. Dr. Calsyn was the Principal Investigator on two NIDA-funded clinical trials: "AIDS Prevention in IV Drug Users," conducted at the VA and at Evergreen Treatment Services and "Comparison of Three Levels of Methadone Intervention," conducted entirely at Evergreen Treatment Services. Both of these projects involved random assignment to various intervention conditions and long term follow-up (18 and 24 months). Dr. Calsyn is also Co-Investigator for HIV-Related Studies on the NIDA Clinical Trials Network project, housed at the Alcohol and Drug Abuse Institute. He is the Lead Investigator of NIDA-CTN-0018 protocol, "Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment."

Primary Research Interests:

• HIV prevention interventions with injection drug users
• Use of contingency management techniques in the treatment of drug abuse

Current Projects:

• NIDA Clinical Trials Network: Washington Node. A multisite network of regional research and training centers working in conjunction with community-based treatment programs to implement and evaluate behavioral and pharmacological interventions with demonstrated efficacy in community-based programs. more...

• Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment (NIDA-CTN-0018). (Dr. Calsyn is Lead Investigator of this CTN Protocol.) This study evaluates a five-session HIV/AIDS group therapy designed specifically for heterosexual men. more...

View all ADAI projects Dr. Calsyn has participated in, both current and completed.

Recent and Representative Publications:

1. Sorensen JL, Brown L, Calsyn DA, Tross S, Booth RE, Song Y, Normand J. AIDS research in the NIDA Clinical Trials Network: emerging results. Drug Alcohol Depend 2007;89(2-3):310-3. (Pubmed abstract) (CAL 07-01)

2. Davison JW, Sweeney ML, Bush KR, Davis Correale TM, Calsyn DA, Reoux JP, Sloan KL, Kivlahan DR. Outpatient treatment engagement and abstinence rates following inpatient opioid detoxification. J Addict Dis 2006;25(4):27-35. (Pubmed abstract) (CAL 06-02)

3. Calsyn DA, Malcy JA, Saxon AJ. Slow tapering from methadone maintenance in a program encouraging indefinite maintenance. J Subst Abuse Treat 2006;30(2):159-163. (Pubmed abstract) (CAL 06-01)

4. Saxon AJ, Malte CA, Sloan KL, Baer JS, Calsyn DA, Nichol P, Chapko MK, Kivlahan DR. Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment. Med Care 2006;44:334-342.  (Pubmed abstract) (BAE 06-01)

5. Calsyn DA, Saxon AJ, Bush KR, Howell DN, Baer JS, Sloan KL, Malte CA, Kivlahan DR. The Addiction Severity Index medical and psychiatric composite scores meaasure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity. Drug Alcohol Depend 2004;76(2):165-71. (Pubmed abstract) (CAL 04-01)

View more publications by Dr. Calsyn.

ADAI Staff | ADAI Research | ADAI Home

Updated 8/2007
http://depts.washington.edu/adai/staff/calsynbio.htm